Trends in retail prices of prescription drugs widely used by older Americans: 2017 year-end update
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Rx price watch
- Author(s):
- Schondelmeyer, Stephen W., author Purvis, Leigh, author
- Contributor(s):
- AARP (Organization), issuing body. Public Policy Institute (AARP (Organization)), issuing body.
- Publication:
- Washington, DC : AARP Public Policy Institute, September 2019
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Drug Costs -- trends Drugs, Generic -- economics Prescription Drugs -- economics United States
- Genre(s):
- Technical Report
- Abstract:
- Retail prices for a combined set of widely used prescription drugs consistently increased faster than general inflation in every year from 2006 to 2017. These findings are primarily attributable to strong drug price growth among brand name and specialty drugs, which more than offset often substantial price decreases among generic drugs. For a consumer who takes a prescription drug on a chronic basis, the average annual cost of therapy for one widely used drug reached almost $20,000 in 2017. Notably, the annual cost of therapy would have been more than $12,500 lower in 2017 if price changes had been limited to the rate of general inflation between 2006 and 2017.
- Copyright:
- Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY-NC-ND license. (More information)
- Extent:
- 1 online resource (1 PDF file (iv, 17 pages))
- Illustrations:
- Illustrations
- NLM Unique ID:
- 101769471 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101769471